Articles

“[Mitomycin gel] is efficacious as a [chemoablation] agent in adult patients with low-grade upper tract urothelial cancer, and while it’s FDA approved for both antegrade and retrograde administration, prior reports are limited to the retrograde experience,” said study investigator Kyle Rose, MD.

Antegrade instillation of mitomycin gel is effective in patients with UTUC

The neoadjuvant combination of the PD-1 inhibitor tislelizumab and nab-paclitaxel induced a high rate of pathologic complete response in patients with muscle-invasive bladder cancer.  

Neoadjuvant chemoimmunotherapy shows promise in MIBC

Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.

The investigators report that no device or procedure-related serious adverse events have occurred.

RENOVA iStim System shows safety in refractory overactive bladder

Treatment with the temporary implantable nitinol device led to a marked reduction in symptoms and improvement in quality of life and functional parameters. 

iTind shows long-term efficacy for LUTS related to benign prostatic obstruction

“With proper training and proper technique, there really can be drastic changes that can be made without having to do a surgical intervention,” commented first author Alissa Tyler, RN.

Aggressive CCH technique is linked to improved curvature in Peyronie disease

Concurrent treatment with intravenous vitamin C and chemotherapy may benefit cisplatin-ineligible patients with locally advanced muscle-invasive bladder cancer.

Vitamin C add-on may benefit MIBC patients receiving chemo

Videos

Katie Murray, DO, discusses findings from a real-world study of antegrade administration of reverse thermal mitomycin gel for primary chemoablation of upper tract urothelial carcinoma via percutaneous nephrostomy tube. 

Dr. Murray on real-world study of antegrade administration of reverse thermal mitomycin gel for UTUC

The hematuria monitor (HM) was discussed in a late-breaking abstract at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.

Open source device monitors hematuria during continuous bladder irrigation

At 2, 3, and 5 weeks after surgery, the stone removal rate was higher in the test group vs the control group (P < .05).

Combination ESWL and extracorporeal physical vibration lithotripsy found safe, efficacious

Neoadjuvant axitinib facilitated partial nephrectomy in patients with an imperative indication for nephron-sparing surgery but no viable strategy to receive the procedure.

AUA